SCANCELL HOLDINGS PLC

Scancell Holdings shares fall 3.01% amid volatility, trading at £91.02. Explore the latest price trends, sector context and company strategy.

Scancell’s shares dip 7% as investors doubt its vaccine platform, leaving a £91 stock that’s still a risky bet amid slow progress and low liquidity.

Scancell Holdings PLC drops 90% in 24‑hr, trading at £90.2. Explore its biotech vaccine platform, market cap £149M, and peer comparison.

Scancell Holdings stalls at £9.3, near its 52‑week low, amid flat market activity – a potential buying zone for value investors eyeing precision‑medicine biotech.